The Proteomics & Biophysics Core (Core B) will provide high-quality reagents and services to support all projects in the program. The reagents include recombinant tau and TREM2 proteins as well as synthetic A? peptides. The Core will also perform comprehensive biophysical measurements on proteins to provide structural information. Additionally, mass spectrometry-based methods, such as quantitative proteomics, hydroxyl radical protein footprinting and mass spectrometry imaging, will be utilized to analyze the chemical composition and spatial distribution of A? and tau aggregates in brain sections, as well as conformational ?footprints? of both A? and tau prions. In addition to using standard ?best-practice? technologies, we will develop and implement several emerging techniques that have recently shown great promise by us and others in the field. For example, hydroxyl radical protein footprinting has been used to study soluble proteins and, more recently, applied to amyloids. This method will be used to obtain conformational differences among prion strains. Moreover, mass spec imaging and traditional immunohistochemistry complement each other. When combined, these two methods will provide more detailed information about the chemical composition and much higher spatial resolutions. Importantly, Core B will be operated by highly experienced biochemists and biophysical chemists to ensure highest quality reagents and services.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG002132-39
Application #
9937161
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
39
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
O'Brien, Connor J; Droege, Daniel G; Jiu, Alexander Y et al. (2018) Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism. J Org Chem 83:8926-8935
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Yang, Bing; Wu, Haifan; Schnier, Paul D et al. (2018) Proximity-enhanced SuFEx chemical cross-linker for specific and multitargeting cross-linking mass spectrometry. Proc Natl Acad Sci U S A 115:11162-11167
Irimata, Katherine E; Dugger, Brittany N; Wilson, Jeffrey R (2018) Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes. Curr Alzheimer Res 15:1032-1044
Nick, Mimi; Wu, Yibing; Schmidt, Nathan W et al. (2018) A long-lived A? oligomer resistant to fibrillization. Biopolymers 109:e23096
Woerman, Amanda L; Watts, Joel C; Aoyagi, Atsushi et al. (2018) ?-Synuclein: Multiple System Atrophy Prions. Cold Spring Harb Perspect Med 8:
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115:409-414
Wang, Tuo; Jo, Hyunil; DeGrado, William F et al. (2017) Water Distribution, Dynamics, and Interactions with Alzheimer's ?-Amyloid Fibrils Investigated by Solid-State NMR. J Am Chem Soc 139:6242-6252
Giles, Kurt; Woerman, Amanda L; Berry, David B et al. (2017) Bioassays and Inactivation of Prions. Cold Spring Harb Perspect Biol 9:

Showing the most recent 10 out of 363 publications